Publications 2013

  1. Comabella M, Rentzsch K, Rio J, Bustamente MF, Borowski K, Stöcker W, Montalban X. Treatment with interferon-beta does not induce anti-nuclear and anti-neuronal serum autoantibodies in multiple sclerosis patients. J Neuroimmunol255(1-2): 102-104 (2013).
  2. Dähnrich C, Komorowski L, Probst C, Seitz-Polski B, Esnault V, Wetzels JF, Hofstra JM, Hoxha E, Stahl RA, Lambeau G, Stöcker W, Schlumberger W. Development of a standardized ELISA for the determination of autoantibodies against human M-type phospholipase A2 receptor in primary membranous nephropathy. Clin Chim Acta 421: 213-218 (2013).
  3. Derksen A, Stettner M, Stöcker W, Seitz RJ. Antiglycine receptor-related stiff limb syndrome in a patient with chronic lymphocytic leukaemia. BMJ Case Reports; doi:10.1136/bcr-2013-008667 (2013).
  4. Finke C, Kopp UA, Scheel M, Pech LM, Soemmer C, Schlichting J, Leypoldt F, Brandt AU, Wuerfel J, Probst C, Ploner CJ, Prüss H, Paul F. Functional and structural brain changes in anti-N-methyl-D-aspartate receptor encephalitis. Ann Neurol, 74(2): 284-296 (2013).
  5. Gosink J. Serological coronavirus diagnostics: From SARS to MERS. MedLab Magazine 3: 010-012 (2013).
  6. Grunow B, Böhmert B, Fechner K. Specificity of antibodies established from mammals in rainbow trout (Oncorynchus mykiss). J Appl Ichthyol 29: 1129-1133 (2013).
  7. Hammer C, Stepniak B, Schneider A, Papiol S, Tantra M, Begemann M, Sirén A-L, Pardo LA, Sperling S, Mohd Jofrry S, Gurvich A, Jensen N, Ostmeier K, Lühder F, Probst C, Martens H, Gillis M, Saher G, Assogna F, Spalletta G, Stöcker W, Schulz TF, Nave K-A, Ehrenreich H. Neuropsychiatric disease relevance of circulating anti-NMDA receptor autoantibodies depends on blood-brain barrier integrity. Mol Psychiatry 1-7; doi: 10.1038/mp.2013.110 (2013).
  8. Jarius S, Martínez-García P, Hernandez AL, Brase JC, Borowski K, Regula JU, Meinck HM, Stöcker W, Wildemann B, Wandinger KP. Two new cases of anti-Ca (anti-ARHGAP26/ GRAF) autoantibody-associated cerebellar ataxia. J Neuroinflammation 10: 7 (2013).
  9. Komorowski L, Mockenhaupt M, Sekula P, Roujeau JC, Probst C, Teegen B, Li W, Stöcker W, Zillikens D. Lack of a specific humoral autoreactivity in sera from patients with early erythema exsudativum multiforme majus. J Invest Dermatol 133(12): 2799-2802 (2013).
  10. Komorowski L, Teegen B, Probst C, Aulinger-Stöcker K, Sina C, Fellermann K, Stöcker W. Autoantibodies against exocrine pancreas in Crohn’s disease are directed against two antigens: the glycoproteins CUZD1 and GP2. Journal of Crohn’s and Colitis 7(10): 780-790 (2013).
  11. Lederer S, Lattwein E, Hanke M, Sonnenberg K, Stöcker W, Lundkvist Å, Vaheri A, Vapalahti O, Chan PKS, Feldmann H, Dick D, Schmidt-Chanasit J, Padula P, Vial PA, Panculescu-Gatej R, Ceianu C, Heyman P, Avšic-Županc T, Niedrig M.Indirect immunofluorescence assay for the simultaneous detection of antibodies against clinically important old and new world hantaviruses. PLoS Neglected Tropical Diseases 7(4): e2157 (2013).
  12. Leypoldt F, Titulaer MJ, Aguilar E, Walther J, Bönstrup M, Havemeister S, Teegen B, Lütgehetmann M, Rosenkranz M, Magnus T, Dalmau J. Herpes simplex virus-1 encephalitis can trigger anti-NMDA receptor encephalitis: Case report. Neurology 81(18): 1637-1639 (2013).
  13. Li J, Shen Y, He J, Jia R, Wang X, Chen X, Wang D, Han L, Zhu L, Chi X, Saschenbrecker S, Dähnrich C, Stöcker W, Schlumberger W, Li ZG. Significance of antibodies against the native ribosomal P protein complex and recombinant P0, P1, and P2 proteins in the diagnosis of Chinese patients with systemic lupus erythematosus. J Clin Lab Anal 27(2): 87-95 (2013).
  14. Mangler M, Trebesch de Perez I, Teegen B, Stöcker W, Prüss H, Meisel A, Schneider A, Vasiljeva J, Speiser D. Seroprevalence of anti-N-methyl-D-aspartate receptor antibodies in women with ovarian teratoma. J Neurol 260(11): 2831-2835 (2013).
  15. Mundiyanapurath S, Jarius S, Probst C, Stöcker W, Wildemann B, Bösel J. GABA-B-receptor antibodies in paraneoplastic brainstem encephalitis. J Neuroimmunol 259(1-2): 88-91(2013).
  16. Papp M, Sipeki N, Vitalis Z, Tornai T, Altorjay I, Tornai I, Udvardy M, Fechner K, Jacobsen S, Teegen B, Sumegi A, Veres G, Lakatos PL, Kappelmayer J, Antal-Szalmas P. High prevalence of IgA class anti-neutrophil cytoplasmic antibodies (ANCA) is associated with increased risk of bacterial infection in patients with cirrhosis. J Hepatol 59(3): 457-466 (2013).
  17. Probst C, Komorowski L, Lange S, Saschenbrecker S, Brix B, Teegen B, Rentzsch K, Stöcker W. Paraneoplastische neurologische Syndrome. Krebsmedizin 22(3): 140-146 (2013).
  18. Probst C, Radzimski C, Blöcker IM, Teegen B, Bogdanos DP, Stöcker W, Komorowski L. Development of a recombinant cell-based indirect immunofluorescence assay (RC-IFA) for the determination of autoantibodies against “rings and rods”-associated inosine-5’-monophosphate dehydrogenase 2 in viral hepatitis C. Clin Chim Acta 418: 91–96 (2013).
  19. Radzimski C, Probst C, Teegen B, Rentzsch K, Blöcker IM, Dähnrich C, Schlumberger W, Stöcker W, Bogdanos DP, Komorowski L. Development of a recombinant cell-based indirect immunofluorescence assay for the determination of autoantibodies against soluble liver antigen in autoimmune hepatitis. Clin Dev Immunol, Vol 2013, doi: 10.1155/2013/572815 (2013).
  20. Rateike M. Indirekte Immunfluoreszenz. Mensch und Technik 3: 10-11 (2013).
  21. Rose T, Grützkau A, Hirseland H, Huscher D, Dähnrich C, Dzionek A, Ozimkowski T, Schlumberger W, Enghard P, Radbruch A, Riemekasten G, Burmester GR, Hiepe F, Biesen R. IFNa and its response proteins, IP-10 and SIGLEC-1, are biomarkers of disease activity in systemic lupus erythematosus. Ann Rheum Dis 72(10): 1639-1645 (2013).
  22. Saschenbrecker S, Rentzsch K, Probst C, Komorowski L, Stöcker W. Antineuronale Autoantikörper: Klinische Bedeutung und Nachweismethoden. Med Welt 64: 21-29 (2013).
  23. Steiner J, Walter M, Glanz W, Sarnyai Z, Bernstein HG, Vielhaber S, Kästner A, Skalej M, Jordan W, Schiltz K, Klingbeil C, Wandinger KP, Bogerts B, Stöcker W. Increased prevalence of diverse N-methyl-D-aspartate glutamate receptor antibodies in patients with an initial diagnosis of schizophrenia: Specific relevance of IgG NR1a antibodies for distinction from N-methyl-D-aspartate glutamate receptor encephalitis. JAMA Psychiatry 70(3): 271-278 (2013).
  24. Stöcker W, Hornig N, Komorowski L, Probst C, Saschenbrecker S, Schlumberger W. Kutane paraneoplastische Syndrome. Krebsmedizin 22(3): 134-139 (2013).
  25. Stöcker W, Saschenbrecker S, Rentzsch K, Komorowski L,Probst C. Autoantikörperdiagnostik in der Neurologie mittels nativer und rekombinanter Antigensubstrate. Der Nervenarzt 84: 471-476 (2013).
  1. Atzeni F, Sarzi-Puttini P, Infantino M, Manfredi M, Olivito O, Benucci M, Meyer W, Ott A. Determination of the serological profiles in anti-Ro52-positive patients with systemic autoimmune rheumatic diseases. European Congress of Rheumatology, EULAR, Madrid, Spain (2013).
  2. Axel K, Krüger C, Steller U, Pfeiffer T. Fast microarray test directly from whole blood for determination of 4 mutations in the HFE gene associated with hereditary haemochromatosis. 20. IFCC-EFLM European Congress of Clinical Chemistry and Laboratory Medicine und 45. Congress of the Italian Society of Clinical Biochemistry and Clinical Molecular Biology (SIBioC), Milan, Italy (2013).
  3. Ens K, Krause C, Saschenbrecker S, Rohwäder E, Fechner K, Stöcker W, Barth E, Martinetz T, Voigt J. Automated indirect immunofluorescence evaluation of antinuclear autoantibodies on HEp-2 cells. 20. IFCC-EFLM European Congress of Clinical Chemistry and Laboratory Medicine und 45. Congress of the Italian Society of Clinical Biochemistry and Clinical Molecular Biology (SIBioC), Milan, Italy (2013).
  4. Haven TR, Jaskowski TD, Suh-Lailam BB, Knapp D, Giles RS, Stöcker W, Tebo AE. Autoantibody class is not restricted in N-methyl-D-aspartate receptor associated limbic encephalitis. 26. Annual Meeting of the Association of Medical Laboratory Immunologists (AMLI), Savannah, USA (2013).
  5. Hochstrate N, Krause C, Ens K, Danckwardt M, Feirer C, Rohwäder E, Hahn M, Affeldt K, Rateike M, Morrin M, Wuttig D, Fechner K, Barth E, Stöcker W, Martinetz T, Voigt J. ANA and ANCA Diagnostics with Computer-Aided Immunofluorescence Microscopy (CAIFM). 41. Kongress der Deutschen Gesellschaft für Rheumatologie (DGRh), Heidelberg/Mannheim, Germany (2013).
  6. Hochstrate N, Rateike M, Morrin M, Voigt J, Feirer C, Wuttig D, Fechner K, Affeldt K, Stöcker W. Computer-Aided Immunofluorescence Microscopy (CAIFM) for ANCA Diagnostics. 16. International Vasculitis & ANCA Workshop, Paris, France (2013).
  7. Jacobs D, Slaets S, Struyfs H, Winderickx J, Engelborghs S, Herbst V, Stoops E, Vanmechelen E. A novel mTau assay for cerebrospinal fluid quantification. AD/PD™ 2013 – The Alzheimer's & Parkinson's Conference, Florence, Italy (2013).
  8. Langenhahn J, Dworschak J, Fink D, Komorowski L, Stöcker W, Westermann J, Zillikens D, Schmidt E, Probst C. Specific immunoadsorption of pathogenic autoantibodies in pemphigus requires the entire ectodomains of desmoglein. International pre IID 2013 Satellite Meeting on Autoimmune Bullous Diseases, Lübeck, Germany (2013).
  9. Meyer W, Probst C, Komorowski L, Ott A, Scheper T, Schlumberger W, Stöcker W, Yan H. Preliminary report: Detection of antibodies against D-3-phosphoglycerate dehydrogenase (PGDH) in autoimmune liver diseases using a line immune assay. 11. Dresdner Symposium on Autoantibodies, Dresden, Germany (2013).
  10. Probst C, Komorowski L, Meyer W, Scheper T, Ott A, Charles PJ, Danko J, Bodoky L, Chinoy H, Schlumberger W. Evaluation of recombinant TIF1g in a line immune assay for the detection of autoantibodies in idiopathic inflammatory myopathies. 11. Dresdner Symposium on Autoantibodies, Dresden, Germany (2013).
  11. Rentzsch K, Blöcker IM, Teegen B, Stöcker W, Graus F, Rogemond V, Hônnorat J, Hulsenboom ESP, Sillevis Smitt PAE, Probst C, Komorowski L. Multi-center validation study of DNER as the target of anti-PCA-Tr autoantibodies associated with paraneoplastic neurological syndrome. 11. Dresdner Symposium on Autoantibodies, Dresden, Germany (2013).
  12. Stoops E, Demeyer L, Struyfs H, Slaets S, Engelborghs S, Moser A, Busse S, Jahn H, Gäbler K, Herbst V. New generation of ß-amyloid immunoassays for the detection of Alzheimer’s disease. AD/PD™ 2013 – The Alzheimer's & Parkinson's Conference, Florence, Italy (2013).
  13. Voigt J, Ens K, Krause C, Rohwäder E, Saschenbrecker S, Kaiser G, Fechner K, Barth E, Martinetz T, Stöcker W. Computer-aided immunofluorescence microscopy (CAIFM) for ANA diagnostics using HEp-2 cells. 14. International Congress on Antiphospholipid Antibodies (APLA) und 4. Latin American Congress on Autoimmunity (LACA) in Rio de Janeiro, Brazil (2013).
  14. Voss J, Krüger C, Steller U. Fast microarray test for the determination of factor V Leiden and factor II prothrombin mutations directly from whole blood. 20. IFCC-EFLM European Congress of Clinical Chemistry and Laboratory Medicine und 45. Congress of the Italian Society of Clinical Biochemistry and Clinical Molecular Biology (SIBioC), Milan, Italy (2013).
  15. Weimann A, Löwe T, Sarraß C, Hartwich P, Suer W, Schlumberger W, Stöcker W. EUROLINE SPAC and EUROBlotOne: Automated multi-parameter component resolved allergy diagnostics. 20. IFCC-EFLM European Congress of Clinical Chemistry and Laboratory Medicine, 45. Congress of the Italian Society of Clinical Biochemistry and Clinical Molecular Biology (SIBioC) und EAACI-WAO-Kongress, Milan, Italy (2013).
  16. Westermann J, Denczyk E, Probst C, Komorowski L, Schlumberger W. Autoantibodies against acetylcholine receptors: A new non-radioactive assay applying the complete epitope spectrum as antigenic target. 11. Dresdner Symposium on Autoantibodies, Dresden, Germany (2013).
  1. Aldag J. 1. Serologische Diagnostik autoimmuner und paraneoplastischer ZNS-Erkrankungen. 2. Antikörper-Nachweis bei bullösen Autoimmundermatosen. Fortbildungsveranstaltung synlab „Minikongress Autoantikörper“, Augsburg, Germany (2013).
  2. Fechner K. 1. Update on ANA screening and differentiation. 2. Diagnostic tools for autoimmune nephropathies. MedLab, Dubai, United Arab Emirates (2013).
  3. Fechner K. Praktische diagnostische Übungen. Kursus für klinische Immunologie bei der Tagung der Deutschen Gesellschaft für Innere Medizin (DGIM), Wiesbaden, Germany (2013).
  4. Fechner K. Update ANA-Diagnostik: Aktuelle ACR-Empfehlungen - automatische IIFT-Mustererkennung. Fortbildungsveranstaltung synlab „Minikongress Autoantikörper“, Augsburg, Germany (2013).
  5. Komorowski L. Autoantibody profiling in idiopathic inflammatory myopathies: Validation of the myositis antigens Mi-2a, MDA5, NXP2 and SAE1 in a line immunoasay. 11. Dresdner Symposium on Autoantibodies, Dresden, Germany (2013).
  6. Probst C. Multi-parametric recombinant cell-based indirect immunofluorescence assay (RC-IFA) for the determination of autoantibodies associated with paraneoplastic neurological syndromes. 11. Dresdner Symposium on Autoantibodies, Dresden, Germany (2013).
  7. Schlumberger W. Evaluation of a new ELISA for the determination of autoantibodies against human M-type phospholipase A2 receptor in primary membranous nephropathy. 11. Dresdner Symposium on Autoantibodies, Dresden, Germany (2013).
  8. Schlumberger W. 1. Autoantibody diagnostics in autoimmune nephropathies. 2. Antibody detection in bullous autoimmune dermatoses. 3. New serologic markers for the diagnosis of autoimmune and paraneoplastic diseases of the CNS. XVII. Casomil Symposium, Kutna Hora, Czech Republic (2013).
  9. Schlumberger W. Autoantibodies against phospholipase-A2 receptors in membranous glomerulonephritis: Clinical and therapeutic implications. 14. International Congress on Antiphospholipid Antibodies & 4. Latin American Congress on Autoimmunity, Rio de Janeiro, Brazil (2013).
  10. Schlumberger W. 1. Innovative technologies: Recombinant cell-based immunofluorescence tests (RC-IFT) and designer antigens in ELISA. 2. Antibody diagnostics in autoimmune nephropathies. 3. New serologic markers for the diagnosis of autoimmune and paraneoplastic diseases of the CNS. 4. Recent trends in the diagnosis of connective tissue diseases. EUROIMMUN Seminar im Rahmen des 47. Congresso Sociedade Brasileiro de Patologia Clinica / Medicina Laboratorial, Sao Paulo, Brazil (2013).
  11. Stöcker W. Autoantibodies against the neuronal surface antigen DPPX: markers for an emerging neurological disease entity. 11. Dresdner Autoantikörper-Symposium, Dresden, Germany (2013).
  12. Stöcker W. From discovery of a neurological autoimmune mechanism to provision of a robust diagnostic reagent. 13. ESNI Course, Porto, Portugal (2013).
  1. Meyer W, Scheper T. Kalibrationsstreifen für einen Immunoblot. International patent application WO2013/041540 (filed 2012).
  2. Morrin M. Vorrichtung und Verfahren zur automatischen Fokussierung für die Mikroskopie schwach leuchtender Substrate. Chinese, European and US patent application CN 103 080 807 (filed 2013), EP 2 609 460 (filed 2013) and US2013/0162804 (filed 2013).
  3. Probst C, Komorowski L, Blöcker I, Mindorf S, Radzimski C. Verfahren zum spezifischen und quantitativen Nachweis von Antikörpern in einer Probe. German and International patent application DE 10 2012 009 948 (filed 2012) and WO 2013/170855 (filed 2013).
  4. Stöcker W. Verfahren zum Nachweis von Anti-NMDA-Rezeptor-Autoantikörpern zum Einsatz in Diagnoseverfahren. Chinese and European patent application CN 103 282 776 (filed 2013) and EP 2 649 448 (filed 2013).
  5. Stöcker W. Verfahren und Vorrichtung zur Bearbeitung von Proben biologischen Materials. German patent application DE 10 2011 118 496 (filed 2011).
  6. Stöcker W. Diagnosekit sowie Verfahren zur Untersuchung einer menschlichen Patientenprobe auf das Vorhandensein Neuromyelitis-optica-spezifischen Antikörpern. European and US patent application EP 2 676 138 (filed 2013) and US2013/0323754 (filed 2013).
  7. Stöcker W, Meyer W, Scheper T, Euken A. Testkit für die Labordiagnostik. European patent application EP 2 660 602 (filed 2013).
  8. Wessel S, Ahlborg F, Schaller C, Falkert M, Morrin M, Maltzahn B. Vorrichtung zur Steuerung einer Pipettiervorrichtung. German patent application DE 10 2011 118 612 (filed 2011).